It is great to be recognised for the hard work that has gone into growing Random42 over the last couple of years.
LONDON (PRWEB UK) 27 February 2018
The annual ranking, which is presented by The PharmaTimes, was first published last year as the Catalyst Pharma Fast 50 and has since merged with Alantra, the global investment bank. Businesses are selected for their rapid revenue growth over the past two years and are often found to be working closely with big pharma.
The analysis divides companies into four distinct sub-sectors – outsourcing; development, wholesale and supply; consulting; and pharmacy chains. Random42 ranked top within the consulting sub-sector this year, with annualised revenue growth of 34 percent over the past two years, receiving an overall ranking, across all four sub-sectors, of thirteen.
Pharma Fast 50 helps notify the pharma industry of the companies to watch out for, and the supplementary analysis provides an in-depth look at the most important trends affecting the industry right now.
Random42 CEO and Medical Director, Ben Ramsbottom, commented:
“It is great to be recognised for the hard work that has gone into growing Random42 over the last couple of years. This has involved broadening our offering into areas such as virtual reality, augmented reality, interactive installations, in addition to furthering our scientific and creative expertise in developing immersive animations. This has clearly been done with the support of a highly skilled team, with the intent of constantly improving the various products that we offer. We look forward to continuing this growth whilst maintaining the high end products that support this expansion.”
For more on the Pharma Fast 50 read the full article.
For further information please contact - Random42 Scientific Communication
A - 51 Great Marlborough Street, London, W1F 7JT
E - email@example.com
T - +44 (0)20 7734 6001
Notes to Editors:
Random42 Scientific Communication is a leading scientific communication studio specialising in medical animation and education, scientific virtual reality, interactive and visually engaging solutions for global pharmaceutical and biotechnology companies. In their 26-year history they have produced core digital assets for over 650 product launches to date and won over 150 industry awards.